Production & Sales

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, with deliveries starting by the end of 2020.

Cannabinoid Purification and Scale-Up on Hipersep^® Pilot

For the outstanding efficiency and scalability, high-performance liquid chromatography (HPLC) has been widely used for purification of high-quality APIs and intermediates in the pharmaceutical industry.

Takeda to divest OTC and select non-core assets in Asia Pacific to Celltrion for up to $278m

Takeda Pharmaceutical announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical products sold exclusively in Asia Pacific to Celltrion Inc. (“Celltrion”), an Incheon, South Korea-based biopharmaceutical company specializing in the research, development and manufacturing of small molecules, biosimilars and innovative drugs.

PureO₃ Dissolved Ozone Sensor

The new pureO₃ Dissolved Ozone Sensor with Intelligent Sensor Management (ISM^®) technology provides robust, reliable measurement with increased stability in pure water applications.

FUJIFILM to invest $928m to expand Danish biologics production facility

Japan-based FUJIFILM said that it will invest nearly JPY100bn ($928m) towards the expansion of its large-scale biologics production facility in Denmark.

ISM Sensors for M800 and M300 Transmitters

METTLER TOLEDO Thornton M800 and M300 ISM process analytical instrumentation provides reliable, accurate measurements of conductivity/resistivity, pH/ORP, dissolved oxygen and dissolved ozone. On-board digital measurement and Intelligent Sensor Management (ISM) technology provide the utmost in convenience and control of sensor performance.

Cipla enters into a licensing agreement with Gilead to expand access to Covid-19 treatment

Cipla has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine Remdesivir, which has been issued an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to treat COVID-19 patients.

Arcturus Therapeutics, Catalent announce partnership to manufacture mRNA-based Covid-19 vaccine

Arcturus Therapeutics Holdings, a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to protect against the SARS-CoV-2 coronavirus.

Default Table Multi-Parameter Transmitter M800

The M800 multi-parameter transmitter provides simultaneous monitoring of one, two or four in-line sensors. It offers measurement of pH/ORP, optical DO, amperometric oxygen (DO as well as O2 gas), conductivity, resistivity, TOC, dissolved ozone, flow and turbidity in pure water as well as process applications.